• Home
  • Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence.

Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence.

Author List
Song S, Hong JC, McDonnell SE, Koong AC, Minsky BD, Chang DT, Liauw SL
Publication
Annals of surgical oncology
Publication ID (Profile URL)
https://researcherprofiles.org/profile/67484783
Publication Year
2012
PubMed ID
22327251
Publication Title
Song S, Hong JC, McDonnell SE, Koong AC, Minsky BD, Chang DT, Liauw SL. Combined modality therapy for rectal cancer: the relative value of posttreatment versus pretreatment CEA as a prognostic marker for disease recurrence. Ann Surg Oncol. 2012 Aug; 19(8):2471-6.